Agathisflavone isolated from <scp><i>Anacardium occidentale</i></scp> suppresses <scp>SIRT1</scp>‐mediated neuroinflammation in <scp>BV2</scp> microglia and neurotoxicity in <scp>APPS</scp>we‐transfected <scp>SH‐SY5Y</scp> cells

Abstract

Agathisflavone is a bioactive compound in Anacardium occidentale . In this study, we investigated inhibition neuroinflammation in BV2 microglia by agathisflavone. Neuroprotective activity of the compound was investigated in differentiated SH‐SY5Y cells. Experiments in lipopolysaccharide (LPS)‐activated BV2 microglia showed that pretreatment with agathisflavone (5–20 μM) produced significant reduction in the release of tumour necrosis factor‐α, interleukin‐6, interleukin‐1β, NO, and PGE 2 from the cells. Immunoblotting experiments also revealed that agathisflavone reduced levels of iNOS and COX‐2 protein. Further studies revealed that agathisflavone reduced neuroinflammation by targeting critical steps in NF‐κB signalling in BV2 microglia. Treatment of SH‐SY5Y cells with conditioned medium from LPS‐activated BV2 microglia produced a significant reduction in neuronal viability. However, conditioned medium from BV2 cells that were stimulated with LPS in the presence of agathisflavone did not induce neurotoxicity. Agathisflavone also produced neuroprotection in APPSwe plasmid‐transfected SH‐SY5Y neurons. The compound further attenuated LPS‐induced and APPSwe plasmid‐induced reduction in SIRT1 in BV2 microglia and SH‐SY5Y, respectively. In the presence of EX527, agathisflavone lost its anti‐inflammatory and neuroprotective activities. Our results suggest that agathisflavone inhibits neuroinflammation in BV2 microglia by targeting NF‐κB signalling pathway. The compound also reduces neurotoxicity through mechanisms that are possibly linked to SIRT1 in the microglia and neurons.